Panacea Life Sciences Holdings, Inc. Accounts Receivable, Allowance for Credit Loss
Panacea Life Sciences Holdings, Inc. (PLSH) had Accounts Receivable, Allowance for Credit Loss of $0 as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Balance Sheet › Assets › Accounts Receivable, after Allowance for Credit Loss
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2024-05-06
- 2024-03-31: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2023-09-30: Accounts Receivable, Allowance for Credit Loss $4.98K.
- 2023-06-30: Accounts Receivable, Allowance for Credit Loss $0.00.
- 2023-03-31: Accounts Receivable, Allowance for Credit Loss $1.38K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 |
| 2023-09-30 | $4.98K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-15 |
| 2023-03-31 | $1.38K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $9.14K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.85K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.85K 10-Q · filed 2022-05-13 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-06 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |